ArticleCancer immunology, immunotherapy : CII2026

αTrop2/αCD3 bispecific protein engager-armed T cells (BATs) exhibit potent antitumor activity against nasopharyngeal carcinoma.

Kwanpirom Suwanchiwasiri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.